Race against time: The export of essential medicines to rwanda

Public Health Ethics 1 (2):89-103 (2008)
Matthew Rimmer, ACIPA, The Australian National University, College of Law, Canberra, ACT, 0200, Australia. Tel.: (02) 61254164; Email: matthew.rimmer{at}anu.edu.au ' + u + '@' + d + ' '//--> Abstract This article considers the significance of the first export of essential medicines under the WTO General Council Decision 2003. In July 2007, Rwanda became the first country to provide a notification under the WTO General Council Decision 2003 of its intent to import a fixed-dose, triple combination HIV/AIDS drug manufactured by the Canadian generic pharmaceutical manufacturer Apotex, Inc. In September 2007, Apotex was granted the first compulsory licence application under Canada's Access to Medicines Regime. This article considers the convoluted and protracted negotiations between the Government of Rwanda, Apotex and three patent holders, GlaxoSmithKline, Boehringer Ingleheim Canada and Shire BioChemical, Inc. It questions the efficiency of this process. This article considers the review of the Jean Chrétien Pledge to Africa Act 2004 (Canada). It is critical of the refusal of the Conservative Government of Canada to make any amendments to the legislation to improve the cost-effective delivery of essential medicines. This article queries the proposed Hong Kong Amendment to the TRIPS Agreement 1994, given the concerns of the Africa Group. It is submitted that it is undesirable to codify the WTO General Council Decision 2003, given its failure to provide a speedy, efficient and cost-effective delivery of essential medicines. CiteULike Connotea Del.icio.us What's this?
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1093/phe/phn011
 Save to my reading list
Follow the author(s)
Edit this record
My bibliography
Export citation
Find it on Scholar
Mark as duplicate
Request removal from index
Revision history
Download options
Our Archive

Upload a copy of this paper     Check publisher's policy     Papers currently archived: 30,803
Through your library
References found in this work BETA
Human Rights and Global Health: A Research Program.Thomas W. Pogge - 2005 - Metaphilosophy 36 (1‐2):182-209.

Add more references

Citations of this work BETA
Access to Medicines.Thomas Pogge - 2008 - Public Health Ethics 1 (2):73-82.
Specifying Rights: The Case of TRIPS.G. Collste - 2011 - Public Health Ethics 4 (1):63-69.

Add more citations

Similar books and articles
Corporate Responsibilities for Access to Medicines.Klaus M. Leisinger - 2009 - Journal of Business Ethics 85 (1):3 - 23.
GlaxoSmithKline and Access to Essential Medicines (B).N. Craig Smith & Anne Duncan - 2005 - Journal of Business Ethics Education 2 (1):123-132.
Added to PP index

Total downloads
7 ( #539,488 of 2,202,776 )

Recent downloads (6 months)
1 ( #301,722 of 2,202,776 )

How can I increase my downloads?

Monthly downloads
My notes
Sign in to use this feature